Cargando…
Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia
BACKGROUND: Patients hoping to preserve their fertility receive conservative treatment with high-dose medroxyprogesterone acetate (MPA) for well-differentiated endometrioid adenocarcinoma (EC) or atypical endometrial hyperplasia (AEH) . Such treatment generally involves frequent intrauterine operati...
Autores principales: | Inoue, Osamu, Hamatani, Toshio, Susumu, Nobuyuki, Yamagami, Wataru, Ogawa, Seiji, Takemoto, Takashi, Hirasawa, Akira, Banno, Kouji, Kuji, Naoaki, Tanaka, Mamoru, Aoki, Daisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714532/ https://www.ncbi.nlm.nih.gov/pubmed/26769300 http://dx.doi.org/10.1186/s12958-015-0136-7 |
Ejemplares similares
-
Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?
por: Yamagami, Wataru, et al.
Publicado: (2018) -
Hypertriglyceridemia is Frequent in Endometrial Cancer Survivors
por: Hirasawa, Akira, et al.
Publicado: (2013) -
Candidate Biomarkers for Genetic and Clinicopathological Diagnosis of Endometrial Cancer
por: Banno, Kouji, et al.
Publicado: (2013) -
Fertility-Sparing Treatment for Endometrial Cancer or Atypical Endometrial Hyperplasia Patients With Obesity
por: Chen, Junyu, et al.
Publicado: (2022) -
Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics
por: Banno, Kouji, et al.
Publicado: (2012)